what companies make glp-1 drugs 2.0: Where the Next Wave of Value Will Be Created GLP-1 Medications for Weight Loss:

Emerging preclinical evidence suggests GLP-1 may influence neuronal survival, synaptic plasticity, and neuroinflammationprocesses that are disrupted in neurodegenerative conditions

Effects of Glucagon Like Peptide-1 Receptor Agonists on the Neurological System Autoradiography of human tissue sections with 125 I-labelled GLP-1 (7-36 amide) revealed a high content of GLP-1R in the central nervous system suggesting its potentially important role in the nervous system (28)

For colorectal cancer, reductions in circulating insulin and systemic inflammation are plausible mechanisms, although further tissue-level validation is needed (Figure 5)

In the same 2025 study by Qeadan and colleagues, individuals with a history of opioid use disorder (n=503,747) prescribed GLP-1 medications had about a 40% lower rate of opioid overdose events during the 2-year follow-up period (Qeadan et al., 2025)

OBrien R, OMalley D

Together, these ingredients may offer a holistic approach to weight loss by increasing energy, supporting metabolic processes, and making it easier to stay active and motivated